Neural network for predicting potential inhibitors of HIV-1
Abstract
There has been developed and used the generative adversarial autoencoder for rational design of potential inhibitors of HIV-1 entry capable of blocking the region of the gp120 protein of the viral shell which is critical for its binding to the target cell.
About the Authors
A. AndrianovBelarus
R. Nikalayeu
Belarus
M. Shuldau
Belarus
I. Bosko
Belarus
A. Tuzikov
Belarus
References
1. Applications of machine learning in drug discovery and development / J. Vamathevan [et al.] // Nat. Rev. Drug Discov. 2019. Vol. 18(6). P. 463–477.
2. Advances and perspectives in applying deep learning for drug design and discovery / C. F. Lipinski [et al.] // Front. Robot. AI. 2019. Vol. 6. P. 108.
3. Jaeger, S. Mol2vec: unsupervised machine learning approach with chemical intuition / S. Jaeger, S. Fulle, S. Turk // J. Chem. Inf. Model. 2018. Vol. 58 (1). P. 27–35.
4. A Machine learning-based method to improve docking scoring functions and its application to drug repurposing / S. L. Kinnings [et al.] // J. Chem. Inf. Model. 2011. Vol. 51 (2). P. 408–419.
5. Protein structure prediction using multiple deep neural networks in the 13th Critical Assessment of Protein Structure Prediction (CASP13) / A.W. Senior [et al.] // Proteins. 2019. Vol. 87(12). P. 1141–1148.
Review
For citations:
Andrianov A., Nikalayeu R., Shuldau M., Bosko I., Tuzikov A. Neural network for predicting potential inhibitors of HIV-1. Science and Innovations. 2021;(5):28-34. (In Russ.)